Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dependovirus | 25 | 2025 | 708 | 5.650 |
Why?
|
| Genetic Therapy | 23 | 2025 | 789 | 5.280 |
Why?
|
| Genetic Vectors | 23 | 2025 | 871 | 3.800 |
Why?
|
| Gene Transfer Techniques | 9 | 2025 | 321 | 2.020 |
Why?
|
| Codon, Nonsense | 6 | 2024 | 58 | 1.630 |
Why?
|
| Mucopolysaccharidosis I | 4 | 2022 | 7 | 1.500 |
Why?
|
| Gene Editing | 8 | 2024 | 316 | 1.310 |
Why?
|
| Iduronidase | 3 | 2022 | 5 | 1.200 |
Why?
|
| Disease Models, Animal | 11 | 2025 | 2179 | 1.130 |
Why?
|
| CRISPR-Cas Systems | 6 | 2024 | 356 | 1.110 |
Why?
|
| Recombination, Genetic | 3 | 2025 | 245 | 1.060 |
Why?
|
| RNA, Transfer | 2 | 2024 | 89 | 1.000 |
Why?
|
| Animals | 38 | 2025 | 20610 | 0.970 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 3387 | 0.950 |
Why?
|
| DNA, Circular | 1 | 2025 | 7 | 0.950 |
Why?
|
| Capsid | 2 | 2025 | 96 | 0.930 |
Why?
|
| 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) | 1 | 2025 | 9 | 0.930 |
Why?
|
| Liver | 3 | 2025 | 849 | 0.920 |
Why?
|
| Maple Syrup Urine Disease | 1 | 2025 | 18 | 0.920 |
Why?
|
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2024 | 4 | 0.910 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2024 | 7 | 0.910 |
Why?
|
| Capsid Proteins | 1 | 2025 | 98 | 0.910 |
Why?
|
| Mice | 28 | 2025 | 10816 | 0.890 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 107 | 0.790 |
Why?
|
| Homeostasis | 1 | 2025 | 370 | 0.770 |
Why?
|
| Transduction, Genetic | 6 | 2025 | 237 | 0.760 |
Why?
|
| Anti-Mullerian Hormone | 5 | 2023 | 66 | 0.750 |
Why?
|
| Phenotype | 3 | 2024 | 1199 | 0.730 |
Why?
|
| Spinal Cord | 3 | 2018 | 204 | 0.690 |
Why?
|
| Mice, Knockout | 2 | 2024 | 2107 | 0.650 |
Why?
|
| Genes, Recessive | 1 | 2018 | 52 | 0.590 |
Why?
|
| Infusions, Spinal | 1 | 2018 | 3 | 0.580 |
Why?
|
| Heterozygote | 1 | 2018 | 169 | 0.570 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 85 | 0.550 |
Why?
|
| Transgenes | 5 | 2025 | 187 | 0.550 |
Why?
|
| Alleles | 1 | 2018 | 447 | 0.530 |
Why?
|
| Humans | 28 | 2025 | 63152 | 0.470 |
Why?
|
| Aminoglycosides | 2 | 2012 | 11 | 0.470 |
Why?
|
| Muscles | 3 | 2019 | 179 | 0.460 |
Why?
|
| Glycosaminoglycans | 2 | 2011 | 19 | 0.450 |
Why?
|
| Mutation | 4 | 2023 | 2604 | 0.450 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2015 | 86 | 0.430 |
Why?
|
| Adenoviridae | 3 | 2022 | 121 | 0.420 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2022 | 38 | 0.390 |
Why?
|
| Designer Drugs | 1 | 2011 | 2 | 0.370 |
Why?
|
| Trisaccharides | 1 | 2011 | 9 | 0.370 |
Why?
|
| Epilepsy | 2 | 2023 | 113 | 0.350 |
Why?
|
| Fibroblasts | 4 | 2023 | 387 | 0.330 |
Why?
|
| Nonsense Mediated mRNA Decay | 3 | 2022 | 27 | 0.310 |
Why?
|
| Ferrets | 1 | 2025 | 12 | 0.240 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2018 | 97 | 0.240 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2023 | 502 | 0.240 |
Why?
|
| Receptors, Transforming Growth Factor beta | 3 | 2021 | 28 | 0.230 |
Why?
|
| Receptors, Peptide | 3 | 2021 | 34 | 0.230 |
Why?
|
| HEK293 Cells | 2 | 2025 | 618 | 0.230 |
Why?
|
| Sialyltransferases | 2 | 2023 | 18 | 0.230 |
Why?
|
| Viral Tropism | 1 | 2025 | 51 | 0.220 |
Why?
|
| Cattle | 1 | 2025 | 307 | 0.220 |
Why?
|
| Recombinational DNA Repair | 2 | 2021 | 25 | 0.220 |
Why?
|
| Serogroup | 3 | 2025 | 35 | 0.220 |
Why?
|
| History, 21st Century | 1 | 2025 | 171 | 0.220 |
Why?
|
| History, 20th Century | 1 | 2025 | 231 | 0.210 |
Why?
|
| Peptide Hormones | 1 | 2023 | 8 | 0.210 |
Why?
|
| Survival of Motor Neuron 2 Protein | 1 | 2023 | 6 | 0.210 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2023 | 7 | 0.210 |
Why?
|
| Macaca mulatta | 1 | 2024 | 250 | 0.210 |
Why?
|
| Transfection | 1 | 2025 | 690 | 0.210 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2023 | 20 | 0.200 |
Why?
|
| Oxadiazoles | 1 | 2022 | 8 | 0.200 |
Why?
|
| Luciferases | 1 | 2022 | 107 | 0.190 |
Why?
|
| Codon, Terminator | 1 | 2022 | 23 | 0.190 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 10 | 0.190 |
Why?
|
| Lung | 2 | 2024 | 952 | 0.180 |
Why?
|
| Tyrosinemias | 1 | 2021 | 20 | 0.180 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2021 | 11 | 0.180 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2021 | 10 | 0.180 |
Why?
|
| Frontotemporal Dementia | 1 | 2023 | 149 | 0.180 |
Why?
|
| Ovarian Follicle | 2 | 2021 | 40 | 0.180 |
Why?
|
| Precision Medicine | 1 | 2022 | 117 | 0.180 |
Why?
|
| Ovary | 1 | 2021 | 99 | 0.170 |
Why?
|
| Mullerian Ducts | 1 | 2019 | 6 | 0.160 |
Why?
|
| Uterus | 1 | 2019 | 42 | 0.160 |
Why?
|
| Bone Resorption | 1 | 2019 | 41 | 0.160 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 40 | 0.150 |
Why?
|
| Ovalbumin | 1 | 2019 | 116 | 0.150 |
Why?
|
| Adrenoleukodystrophy | 1 | 2018 | 8 | 0.150 |
Why?
|
| Genes, Reporter | 3 | 2018 | 255 | 0.150 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 700 | 0.150 |
Why?
|
| Endonucleases | 2 | 2018 | 82 | 0.150 |
Why?
|
| DNA End-Joining Repair | 2 | 2018 | 23 | 0.150 |
Why?
|
| Osteoporosis | 1 | 2019 | 106 | 0.150 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2018 | 6 | 0.150 |
Why?
|
| Infusions, Intraventricular | 1 | 2018 | 12 | 0.150 |
Why?
|
| Immunity, Cellular | 1 | 2019 | 175 | 0.150 |
Why?
|
| Mice, Transgenic | 4 | 2018 | 1275 | 0.150 |
Why?
|
| Osmotic Pressure | 1 | 2018 | 16 | 0.150 |
Why?
|
| Bone and Bones | 1 | 2019 | 139 | 0.140 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 24 | 0.140 |
Why?
|
| Catheters, Indwelling | 1 | 2018 | 69 | 0.140 |
Why?
|
| Inverted Repeat Sequences | 1 | 2017 | 14 | 0.140 |
Why?
|
| Ovarian Reserve | 1 | 2017 | 9 | 0.130 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2018 | 94 | 0.130 |
Why?
|
| Biological Transport | 1 | 2018 | 291 | 0.130 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2018 | 69 | 0.130 |
Why?
|
| Contraceptive Agents | 1 | 2017 | 12 | 0.130 |
Why?
|
| Genetic Engineering | 1 | 2018 | 116 | 0.130 |
Why?
|
| Gene Silencing | 1 | 2019 | 394 | 0.130 |
Why?
|
| Embryonic Development | 1 | 2018 | 135 | 0.130 |
Why?
|
| Genome, Viral | 1 | 2017 | 136 | 0.130 |
Why?
|
| DNA, Viral | 1 | 2017 | 232 | 0.130 |
Why?
|
| Superoxide Dismutase | 1 | 2017 | 225 | 0.120 |
Why?
|
| Prostate | 1 | 2015 | 85 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2015 | 189 | 0.110 |
Why?
|
| Targeted Gene Repair | 1 | 2014 | 3 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2022 | 788 | 0.110 |
Why?
|
| RNA Editing | 1 | 2014 | 23 | 0.110 |
Why?
|
| Clinical Trials as Topic | 2 | 2014 | 452 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2015 | 145 | 0.110 |
Why?
|
| Base Sequence | 2 | 2019 | 1329 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 201 | 0.110 |
Why?
|
| Female | 9 | 2025 | 32709 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 157 | 0.100 |
Why?
|
| RNA Splicing | 1 | 2014 | 162 | 0.100 |
Why?
|
| Bacterial Proteins | 2 | 2018 | 765 | 0.100 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2014 | 143 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1183 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2019 | 674 | 0.100 |
Why?
|
| Peptide Chain Termination, Translational | 1 | 2012 | 18 | 0.100 |
Why?
|
| Gene Expression Profiling | 2 | 2019 | 765 | 0.090 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 403 | 0.090 |
Why?
|
| Biological Assay | 1 | 2011 | 58 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 660 | 0.090 |
Why?
|
| Male | 7 | 2025 | 29717 | 0.090 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 156 | 0.090 |
Why?
|
| RNA Interference | 1 | 2014 | 618 | 0.090 |
Why?
|
| Lysosomes | 1 | 2011 | 167 | 0.090 |
Why?
|
| Femur | 1 | 2010 | 53 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2010 | 189 | 0.080 |
Why?
|
| Absorptiometry, Photon | 1 | 2010 | 76 | 0.080 |
Why?
|
| Contraception | 2 | 2023 | 71 | 0.080 |
Why?
|
| Brain | 1 | 2018 | 1553 | 0.080 |
Why?
|
| Microscopy, Electron | 1 | 2010 | 250 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 131 | 0.080 |
Why?
|
| Bone Density | 1 | 2010 | 134 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 542 | 0.070 |
Why?
|
| Spleen | 1 | 2010 | 483 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2010 | 579 | 0.070 |
Why?
|
| Injections, Spinal | 2 | 2018 | 46 | 0.070 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 1989 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2013 | 1536 | 0.070 |
Why?
|
| Heart Failure | 1 | 2014 | 912 | 0.060 |
Why?
|
| Green Fluorescent Proteins | 2 | 2018 | 364 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2025 | 293 | 0.060 |
Why?
|
| Neoplasms | 1 | 2014 | 1358 | 0.050 |
Why?
|
| Population Control | 1 | 2023 | 3 | 0.050 |
Why?
|
| Sterilization, Reproductive | 1 | 2023 | 8 | 0.050 |
Why?
|
| Animals, Wild | 1 | 2023 | 13 | 0.050 |
Why?
|
| Macaca fascicularis | 1 | 2023 | 47 | 0.050 |
Why?
|
| Gangliosides | 1 | 2023 | 18 | 0.050 |
Why?
|
| Cats | 1 | 2023 | 87 | 0.050 |
Why?
|
| Dipeptides | 1 | 2023 | 67 | 0.050 |
Why?
|
| DNA Repeat Expansion | 1 | 2023 | 58 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2018 | 1461 | 0.050 |
Why?
|
| C9orf72 Protein | 1 | 2023 | 114 | 0.050 |
Why?
|
| Rare Diseases | 1 | 2022 | 42 | 0.050 |
Why?
|
| United States Food and Drug Administration | 1 | 2022 | 91 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2023 | 212 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 284 | 0.040 |
Why?
|
| Inhibins | 1 | 2021 | 50 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2021 | 236 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 113 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 173 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 619 | 0.040 |
Why?
|
| Cartilage | 1 | 2019 | 34 | 0.040 |
Why?
|
| Fertility | 1 | 2019 | 81 | 0.040 |
Why?
|
| Antibody Formation | 1 | 2019 | 113 | 0.040 |
Why?
|
| Antigen-Presenting Cells | 1 | 2019 | 178 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2019 | 181 | 0.040 |
Why?
|
| Osteoblasts | 1 | 2019 | 198 | 0.040 |
Why?
|
| Fallopian Tubes | 1 | 2018 | 11 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2019 | 307 | 0.040 |
Why?
|
| Astrocytes | 1 | 2018 | 119 | 0.040 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2017 | 8 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2017 | 30 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2017 | 40 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 266 | 0.030 |
Why?
|
| Proteins | 1 | 2023 | 751 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 881 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2018 | 247 | 0.030 |
Why?
|
| Blastocyst | 1 | 2018 | 72 | 0.030 |
Why?
|
| Gene Order | 1 | 2017 | 32 | 0.030 |
Why?
|
| Rats | 1 | 2021 | 1977 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 92 | 0.030 |
Why?
|
| Granulosa Cells | 1 | 2017 | 16 | 0.030 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2017 | 8 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 878 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 1645 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 117 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 111 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 760 | 0.030 |
Why?
|
| Reproduction | 1 | 2017 | 92 | 0.030 |
Why?
|
| Plasmids | 1 | 2017 | 291 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 239 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2019 | 524 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 377 | 0.030 |
Why?
|
| Serotyping | 1 | 2015 | 51 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2021 | 1348 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 27 | 0.030 |
Why?
|
| Tropism | 1 | 2015 | 16 | 0.030 |
Why?
|
| Ascites | 1 | 2015 | 21 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 36 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 413 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 67 | 0.030 |
Why?
|
| Lidocaine | 1 | 2015 | 33 | 0.030 |
Why?
|
| Injections | 1 | 2015 | 81 | 0.030 |
Why?
|
| Punctures | 1 | 2015 | 64 | 0.030 |
Why?
|
| DNA Replication | 1 | 2017 | 234 | 0.030 |
Why?
|
| Cytokines | 1 | 2019 | 934 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 193 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 674 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2015 | 130 | 0.030 |
Why?
|
| Gene Expression | 1 | 2017 | 837 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2015 | 489 | 0.030 |
Why?
|
| Cell Line | 1 | 2017 | 2036 | 0.020 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2012 | 23 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2012 | 76 | 0.020 |
Why?
|
| Models, Biological | 1 | 2017 | 1176 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 504 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 980 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 908 | 0.020 |
Why?
|
| Pregnancy | 1 | 2018 | 2328 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 2012 | 317 | 0.020 |
Why?
|
| United States | 1 | 2022 | 7827 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2152 | 0.020 |
Why?
|
| Inflammation | 1 | 2015 | 1144 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 5429 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2015 | 3033 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 14333 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 16736 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 17480 | 0.010 |
Why?
|